Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease
Alimentary Pharmacology & Therapeutics · 2024-06 · 59 (11) · 1435-1445
DOI: 10.1111/apt.17968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 23.04.2024. Verfasst von Agnès Fernández-Clotet und 10 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Crohn Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National R & D & I Program and co-financed by the ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).
Abstract (Originalsprache)
Background and Aims Magnetic resonance enterography (MRE) depicts transmural changes in response to biological treatment for Crohn's disease (CD); however, the long‐term prognostic significance of these findings is unknown. The primary objective of this study was to identify findings on MRE 46 weeks after initiating biological treatment that predict adverse long‐term outcomes.
Methods
Patients with CD underwent MRE 46 weeks after initiating biological treatment and were prospectively followed for 2 years. A logistic regression analysis was performed to assess the prognostic value of different radiologic findings for various predefined adverse outcomes.
Results
Of the 89 patients included, 46 (51.7%) had ≥1 adverse outcome during follow‐up: 40 (44.9%) had clinical recurrence; 18 (20.2%) required surgery, 8 (9%) endoscopic balloon dilation, 12 (13.5%) hospitalization and 7 (7.8%) required corticosteroids. In the multivariate analysis, persistence of severe lesions (MaRIA ≥11) in any intestinal segment was associated with an increased risk of surgery [OR 11.6 (1.5–92.4)], of surgery and/or endoscopic balloon dilation [OR 6.3 (1.3–30.2)], and of clinical relapse [OR 4.6 (1.6–13.9)]. Penetrating lesions were associated with surgery [OR 3.4 (1.2–9.9)]. Creeping fat with hospitalization [OR 5.1 (1.1–25.0)] and corticosteroids requirement [OR 16.0 (1.2–210.0)]. The presence of complications (stricturing and/or penetrating lesions) was associated with having ≥1 adverse outcome [OR 3.35 (1.3–8.5)].
Conclusion
MRE findings at week‐46 after initiating biological therapy can predict long‐term adverse outcomes in CD. Therapeutic intervention may be required in patients with persistence of severe inflammatory lesions, CD‐associated complications, or creeping fat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- IBD Unit, Radiology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
ORCID-Profile: Agnès Fernández-Clotet, Ingrid Ordás, Jordi Rimola
Förderung
- National R & D & I Program and co-financed by the ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER)
Zitieren
APA
Fernández-Clotet, A., Ordás, I., Masamunt, M. C., Caballol, B., Rodríguez, S., Gallego, M., Barastegui, R., Saavedra, A. C., Panés, J., Ricart, E., & Rimola, J. (2024). Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics, 59(11), 1435-1445. https://doi.org/10.1111/apt.17968
Vancouver
Fernández-Clotet A, Ordás I, Masamunt MC, Caballol B, Rodríguez S, Gallego M, et al. Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics. 2024;59(11):1435-1445. doi:10.1111/apt.17968
BibTeX
@article{FernndezClotet2024,
author = {Fernández-Clotet, Agnès and Ordás, Ingrid and Masamunt, Maria Carme and Caballol, Berta and Rodríguez, Sonia and Gallego, Marta and Barastegui, Rebeca and Saavedra, Anny Carolina and Panés, Julián and Ricart, Elena and Rimola, Jordi},
title = {Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
volume = {59},
number = {11},
pages = {1435--1445},
doi = {10.1111/apt.17968}
}
EUVIMED